236 related articles for article (PubMed ID: 18369469)
1. A new family of lysozyme inhibitors contributing to lysozyme tolerance in gram-negative bacteria.
Callewaert L; Aertsen A; Deckers D; Vanoirbeek KG; Vanderkelen L; Van Herreweghe JM; Masschalck B; Nakimbugwe D; Robben J; Michiels CW
PLoS Pathog; 2008 Mar; 4(3):e1000019. PubMed ID: 18369469
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for the inhibition of human lysozyme by PliC from Brucella abortus.
Um SH; Kim JS; Kim K; Kim N; Cho HS; Ha NC
Biochemistry; 2013 Dec; 52(51):9385-93. PubMed ID: 24308818
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis of bacterial defense against host lysozymes: X-ray structures of periplasmic lysozyme inhibitors PliI and PliC.
Leysen S; Van Herreweghe JM; Callewaert L; Heirbaut M; Buntinx P; Michiels CW; Strelkov SV
J Mol Biol; 2011 Feb; 405(5):1233-45. PubMed ID: 21146533
[TBL] [Abstract][Full Text] [Related]
4. Protecting Gram-negative bacterial cell envelopes from human lysozyme: Interactions with Ivy inhibitor proteins from Escherichia coli and Pseudomonas aeruginosa.
Liu Z; García-Díaz B; Catacchio B; Chiancone E; Vogel HJ
Biochim Biophys Acta; 2015 Nov; 1848(11 Pt B):3032-46. PubMed ID: 25838125
[TBL] [Abstract][Full Text] [Related]
5. Role of lysozyme inhibitors in the virulence of avian pathogenic Escherichia coli.
Vanderkelen L; Ons E; Van Herreweghe JM; Callewaert L; Goddeeris BM; Michiels CW
PLoS One; 2012; 7(9):e45954. PubMed ID: 23049900
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for the recognition of lysozyme by MliC, a periplasmic lysozyme inhibitor in Gram-negative bacteria.
Yum S; Kim MJ; Xu Y; Jin XL; Yoo HY; Park JW; Gong JH; Choe KM; Lee BL; Ha NC
Biochem Biophys Res Commun; 2009 Jan; 378(2):244-8. PubMed ID: 19028453
[TBL] [Abstract][Full Text] [Related]
7. Identification of a bacterial inhibitor against g-type lysozyme.
Vanderkelen L; Van Herreweghe JM; Vanoirbeek KG; Baggerman G; Myrnes B; Declerck PJ; Nilsen IW; Michiels CW; Callewaert L
Cell Mol Life Sci; 2011 Mar; 68(6):1053-64. PubMed ID: 20734102
[TBL] [Abstract][Full Text] [Related]
8. Role of the lysozyme inhibitor Ivy in growth or survival of Escherichia coli and Pseudomonas aeruginosa bacteria in hen egg white and in human saliva and breast milk.
Deckers D; Vanlint D; Callewaert L; Aertsen A; Michiels CW
Appl Environ Microbiol; 2008 Jul; 74(14):4434-9. PubMed ID: 18515493
[TBL] [Abstract][Full Text] [Related]
9. Structure and evolution of the Ivy protein family, unexpected lysozyme inhibitors in Gram-negative bacteria.
Abergel C; Monchois V; Byrne D; Chenivesse S; Lembo F; Lazzaroni JC; Claverie JM
Proc Natl Acad Sci U S A; 2007 Apr; 104(15):6394-9. PubMed ID: 17405861
[TBL] [Abstract][Full Text] [Related]
10. SliC is a surface-displayed lipoprotein that is required for the anti-lysozyme strategy during Neisseria gonorrhoeae infection.
Zielke RA; Le Van A; Baarda BI; Herrera MF; Acosta CJ; Jerse AE; Sikora AE
PLoS Pathog; 2018 Jul; 14(7):e1007081. PubMed ID: 29975784
[TBL] [Abstract][Full Text] [Related]
11. Periplasmic lysozyme inhibitor contributes to lysozyme resistance in Escherichia coli.
Deckers D; Masschalck B; Aertsen A; Callewaert L; Van Tiggelen CG; Atanassova M; Michiels CW
Cell Mol Life Sci; 2004 May; 61(10):1229-37. PubMed ID: 15141308
[TBL] [Abstract][Full Text] [Related]
12. The Rcs two-component system regulates expression of lysozyme inhibitors and is induced by exposure to lysozyme.
Callewaert L; Vanoirbeek KG; Lurquin I; Michiels CW; Aertsen A
J Bacteriol; 2009 Mar; 191(6):1979-81. PubMed ID: 19136591
[TBL] [Abstract][Full Text] [Related]
13. Lysozyme inhibitor conferring bacterial tolerance to invertebrate type lysozyme.
Van Herreweghe JM; Vanderkelen L; Callewaert L; Aertsen A; Compernolle G; Declerck PJ; Michiels CW
Cell Mol Life Sci; 2010 Apr; 67(7):1177-88. PubMed ID: 20049505
[TBL] [Abstract][Full Text] [Related]
14. Structural characterization of the PliG lysozyme inhibitor family.
Leysen S; Vanderkelen L; Van Asten K; Vanheuverzwijn S; Theuwis V; Michiels CW; Strelkov SV
J Struct Biol; 2012 Oct; 180(1):235-42. PubMed ID: 22634186
[TBL] [Abstract][Full Text] [Related]
15. Inheritance of the lysozyme inhibitor Ivy was an important evolutionary step by Yersinia pestis to avoid the host innate immune response.
Derbise A; Pierre F; Merchez M; Pradel E; Laouami S; Ricard I; Sirard JC; Fritz J; Lemaître N; Akinbi H; Boneca IG; Sebbane F
J Infect Dis; 2013 May; 207(10):1535-43. PubMed ID: 23402825
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori peptidoglycan modifications confer lysozyme resistance and contribute to survival in the host.
Wang G; Lo LF; Forsberg LS; Maier RJ
mBio; 2012 Dec; 3(6):e00409-12. PubMed ID: 23221800
[TBL] [Abstract][Full Text] [Related]
17. Genetically enhanced lysozyme evades a pathogen derived inhibitory protein.
Dostal SM; Fang Y; Guerrette JC; Scanlon TC; Griswold KE
ACS Chem Biol; 2015 Apr; 10(4):1110-7. PubMed ID: 25607237
[TBL] [Abstract][Full Text] [Related]
18. Cell wall substrate specificity of six different lysozymes and lysozyme inhibitory activity of bacterial extracts.
Nakimbugwe D; Masschalck B; Deckers D; Callewaert L; Aertsen A; Michiels CW
FEMS Microbiol Lett; 2006 Jun; 259(1):41-6. PubMed ID: 16684100
[TBL] [Abstract][Full Text] [Related]
19. Effect of Lipidation on the Localization and Activity of a Lysozyme Inhibitor in
Ragland SA; Gray MC; Melson EM; Kendall MM; Criss AK
J Bacteriol; 2020 Mar; 202(8):. PubMed ID: 32041800
[TBL] [Abstract][Full Text] [Related]
20. Targeting the permeability barrier and peptidoglycan recycling pathways to disarm Pseudomonas aeruginosa against the innate immune system.
Torrens G; Pérez-Gallego M; Moya B; Munar-Bestard M; Zamorano L; Cabot G; Blázquez J; Ayala JA; Oliver A; Juan C
PLoS One; 2017; 12(7):e0181932. PubMed ID: 28742861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
